Printer Friendly

Cantel Medical to Acquire Sterility Assurance Products Division from NAMSA for USD 13.5m.


4 March 2016 - US-based medical technology company Cantel Medical Corp. (NYSE: CMN), has closed an agreement with North American Science Associates, Inc. (NAMSA) to acquire NAMSA's Sterility Assurance Monitoring Products division for USD 13.5m in cash consideration, the company said.

For the year ending December 31, 2015 this business had adjusted sales of USD 5.7m.

The Sterility Assurance Monitoring Products division manufactures a broad suite of biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes.

These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Cantel's Healthcare Disposables segment.

Cantel expects the transaction to be neutral to GAAP earnings per share and slightly accretive to Non-GAAP earnings per share in fiscal year ending July 31, 2016 and accretive to both GAAP and non-GAAP earnings per share in fiscal year 2017 and beyond.

NAMSA's sterility assurance products will be integrated into the Crosstex product portfolio and reported in the Healthcare Disposables segment.

Cantel Medical's products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, and hollow fiber membrane filtration and separation products.

Crosstex, a Cantel Medical company, manufactures a range of infection prevention and compliance products for the global healthcare industry.

Country: USA

Sector: Healthcare

Target: NAMSA's Sterility Assurance Monitoring Products division

Buyer: Cantel Medical Corp.

Vendor: North American Science Associates, Inc

Deal size in USD: 13.5m

Type: Corporate Acquisition

Financing: Cash

Status: Closed

Buyer advisor: , ,


COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Mar 4, 2016
Previous Article:Cerberus Closes Acquisition of Majority Stake in Avon's North America Business.
Next Article:AllianceBernstein Income Fund Wins Shareholder Approval for Acquisition of Assets by AB Income Fund.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters